Search
INTRODUCTION Just as the coronavirus mutates to survive and thrive, so to do the purveyors of counterfeit medicines – with their high-speed “host” being the digi-tization of patient care. The future is now. So, how do we balance moving forward with user-friendly digitization, telemedicine and virtual healthcare delivery while simultaneously recognizing the unintended consequences of the innovative criminal mind? The…
Read MoreIn this analysis, which was published in Lexology on October 13, 2020, three global regulatory experts examine barriers to drug importation.
Read MoreIn PSM’s round-up this week: Policy truths about drug importation, prosecutions for fake COVID-19 treatments and financial fraud, and another week in counterfeit pills.
Read More